4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Back to Agenda

Session 6: Convergence of Regulatory Science and Medical Practice: Are We On Track?

Session Chair(s)

Steinar Madsen, MD

Medical Director

Norwegian Medicines Agency, Norway

The session will be a round table discussion with short presentations from each speakers.

Speaker(s)

Norwegian View

Steinar Madsen, MD

Norwegian Medicines Agency, Norway

Medical Director

Biosimilar Position Statements from Medical Associations – a further regulatory hurdle for new drugs or a distraction?

Arnold Vulto, PharmD, PhD

Erasmus University Medical Center Rotterdam, Netherlands

Em. Professor of Hospital Pharmacy & Practical Therapeutics

Perspective from the Regulators

Thijs Giezen, PharmD, PhD, MSc

Medicines Evaluation Board, Netherlands

Payer's Perspective

Lonneke Timmers, PharmD, PhD

Menzis Health Insurance, Netherlands

Views from Health Care Professionals and Patients

Neil Betteridge

European League Against Rheumatism (EULAR), Switzerland

International Liaison Officer, Public Affairs

Have an account?

4th European Biosimilars Conference

Session 6: Convergence of Regulatory Science and Medical Practice: Are We On Track?

Session Chair(s)

Steinar Madsen, MD

Speaker(s)

Norwegian View

Biosimilar Position Statements from Medical Associations – a further regulatory hurdle for new drugs or a distraction?

Perspective from the Regulators

Payer's Perspective

Views from Health Care Professionals and Patients

Be informed and stay engaged.